Biocon Biologics appoints Shreehas Tambe as new MD, CEO

Published On 2022-12-06 11:49 GMT   |   Update On 2022-12-06 11:49 GMT

Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced today that Shreehas Tambe, Deputy CEO of Biocon Biologics, has been appointed as the Managing Director and CEO of the Company from December 5, 2022. Tambe takes over from Dr Arun Chandavarkar, who will continue to serve as a non-Executive, non-Independent Director on the Board of Biocon Biologics.For more details, check out the...

Login or Register to read the full article

Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced today that Shreehas Tambe, Deputy CEO of Biocon Biologics, has been appointed as the Managing Director and CEO of the Company from December 5, 2022.

Tambe takes over from Dr Arun Chandavarkar, who will continue to serve as a non-Executive, non-Independent Director on the Board of Biocon Biologics.

For more details, check out the link given below:

Biocon Biologics Names Shreehas Tambe As New MD, CEO

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News